(WHO/NCD/NCS/99.2).
14- Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001, 44 Suppl 2:S14–S21.
15- Global data on visual impairments 2010. Geneva, World Health Organization, 2012.
16- Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care, 2005, 28(9):2130–2135.
17- Hernanz R. Farmacoterapia Básica en la Paliación. En: Astudillo W, Morales A, Clave E, Cabares A, Urdaneta E. Avances resientes en cuidados paliativos. 1ed. España. Sociedad Vasca de Cuidados Paliativos; 2002.p.89- 110
18- Foliy Kathleen M. Suppotive Care and Quality of Life. Pain. En: De Vita Vicent T,Hellman S, Rosenberg SA. Cancer. Principles on Practice of Oncology on (CD- ROM). Ged. Philadelphia: Lippicott Williams and Williams ; 200112
19- Nebot Sanz MT, Aspectos psicoemocionales y comunicación con el paciente terminal y su familia. En: Espejo Arias MD. Cuidados Paliativos. Madrid: Difusión Avances de Enfermeria ; 2000.p.189- 196
20- Murrillo Duque E. La Calida de vida del enfermo neoplásico. En: Cortes- Fuentes, et al. Oncológica Médica. Madrid. Libros Princisp: Biblioteca Aula Medica; 1999.p.1717- 1732
21- Jose I, Mayordomo Camora, Raquel Andres Conejero. Melanoma Maligno.En: Cortés- Funes H, Colomer Bosch R, Alba Conejo E, Díaz- Rubio E, Gonzá Caturla M, Trigo Pérez JM. Tratado de Oncología.T.2. Mallorca: PUBLICACIONES PERMANYER; 2009. p. 371- 420.
22- Dolores Isla Casodo,., Raquel Andres Conejero.Cáncer de Cavidad oral.En: Cortés- Funes H, Colomer Bosch R, Alba Conejo E, Díaz- Rubio E, Gonzá Caturla M, Trigo Pérez JM. Tratado de Oncología. T.2. Mallorca: PUBLICACIONES PERMANYER; 2009. p. 191- 208.
23- Eduardo Diaz Rubio.Efctos secundarios de la quimioterapia.En: Cortés- Funes H, Colomer Bosch R, Alba Conejo E, Díaz- Rubio E, Gonzá Caturla M, Trigo Pérez JM. Tratado de Oncología.T.2. Mallorca: PUBLICACIONES PERMANYER; 2009. p. 819- 886.
24- Jesús Garcia Mata, Andres Garcia Palomo, Jesús Garcia Perez.Quimioterapia antineoplasica.En: Cortés- Funes H, Colomer Bosch R, Alba Conejo E, Díaz- Rubio E, Gonzá Caturla M, Trigo Pérez JM. Tratado de Oncología.T.1. Mallorca: PUBLICACIONES PERMANYER; 2009. p. 219- 260.
25- Xiaomei Ma,Hebert Yu. Epidemiology of Cancer.De Vita,Vincent.; Laurance, Teodore S.; Rosenbert. Principles Practice of Oncology,8th Edition,Volume one, Part 2, Chapter 19;2008
26- Camacho Rodríguez R. El problema Cáncer en Cuba.Una Estrategia científica de abordaje. La Habana: MINSAP; 2001
27- Comunicación. Cáncer en Cuba. Registro Nacional de Cáncer. INOR; 2005
28- Zacca Peña CE. Mortalidad. En: Anuario estadístico de salud. La Habana: MINSAP; 2010.
29- Normas Nacionales de Procedimientos y Diagnostico en oncología.. La Habana: Ciencias Médicas ; 2007
30- Datos estadisticos pertencientes al archivo del Hospital Roberto Rodriguez
31- Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685PubMedCrossRef
32- Smith U, Gale EAM (2009) Does diabetes therapy influence the risk of cancer? Diabetologia 52:1699–1708PubMedCrossRef
33- Golder S, Loke YK, Bland M (2011) Meta- analyses of adverse effects data derived from randomized controlled trials as compared to observational studies; methodological overview. PLoS Med 8:e1001026PubMedCrossRef
34- PLoS Medicine Editors (2011) Why drug safety should not take a back seat to efficacy. PLoS Med 8:e1001097. doi:10.1371/journal.pmed.1001097 CrossRef
35- Johnson JA, Gale EA (2010) Diabetes, insulin use and cancer risk: are observational studies part of the solution—or part of the problem? Diabetes 59:1129–1131PubMedCrossRef
36- Renehan AG, Yeh HC, Johnson JA, Wild SH, Gale EAM, Moller H. (2012) Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia doi:10.1007/s00125- 012- 2526- 0
37- Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103–1123PubMedCrossRef
10.
38- Nicolucci A (2010) Epidemiological aspects of neoplasms in diabetes. Acta Diabetol 47:87–95PubMedCrossRef
39- Larsson SC, Wolk A (2011) Diabetes mellitus and incidence of kidney cancer: a meta- analysis of cohort studies. Diabetologia 54:1013–1018PubMedCrossRef
40- Noto H, Osame K, Sasazuki T, Noda M (2010) Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta- analysis of epidemiologic evidence in Japan. J Diabetes Complications 24:345–353PubMedCrossRef
41- Swerdlow AJ, Laing SP, Qiao Z et al (2005) Cancer incidence and mortality in patients with insulin- treated diabetes: a UK cohort study. Br J Cancer 92:2070–2075PubMedCrossRef
42- Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K (2010) Cancer risk among patients hospitalized for type 1 diabetes mellitus: a population- based cohort study in Sweden. Diabet Med 27:791–797PubMedCrossRef
43- Tabak AG, Jokela M, Akbaraly TN, Kivimaki M, Witte D (2009) Trajectories of glycemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215–2221PubMedCrossRef
44- Pollak M (2008) Insulin and insulin- like growth factor signaling in neoplasia. Nat Rev Cancer 8:915–928PubMedCrossRef
45- Vella V, Pandini G, Sciacca L et al (2002) A novel autocrine loop involving IGF- II and the insulin receptor isoform- A stimulates growth of thyroid cancer. J Clin Endocrinol Met 87:245–254CrossRef
46- Goodwin PJ (2008) Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions? J Clin Oncol 26:833–834PubMedCrossRef
47- van Kruijsdijk RC, van der Wall E, Visseren FL (2009) Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 18:2569–2578PubMedCrossRef
48- Gerstein HC (2010) Does insulin therapy promote, reduce, or have a neutral effect on cancers? JAMA